Highlight
Lubiprostone administration in CKD patients preserved estimated glomerular filtration rate (eGFR) and slowed renal decline over 24 weeks without altering uremic toxin levels.
Multiomics analyses revealed lubiprostone increased gut microbial agmatine deiminase (aguA) expression, resulting in elevated spermidine, a polyamine beneficial for mitochondrial function.
